Latest

Bringing synthetic biology to the market: an Australia and Singapore perspective

2022-09-27T15:09:29+08:00

In partnership with Synthetic Biology Australasia, SINERGY organized a webinar on “Bringing synthetic biology to market: an Australia and Singapore perspective” on Tuesday, 2 August 2022. Here you can watch recordings of the startup and investor panel discussions from the webinar, and gain insights into what entrepreneurs and founders from Australia and Singapore had to say.

Bringing synthetic biology to the market: an Australia and Singapore perspective2022-09-27T15:09:29+08:00

SINERGY speaks to Emily Leproust from Twist Bioscience

2022-07-13T13:36:09+08:00

What is the secret of successful Synthetic Biology company? According to Emily Leproust, CEO of Twist Bioscience, it all depends on people. In this interview, Sierin Lim explores the journey of Emily Leproust as a scientist and entrepreneur, how Twist was made, what motivated her, as well as her advice to aspiring scientists and entrepreneurs in Biotech and Synthetic Biology.

SINERGY speaks to Emily Leproust from Twist Bioscience2022-07-13T13:36:09+08:00

Combining synthetic, computational, and structural biology improves key enzyme in cannabinoid biosynthesis

2022-05-18T12:58:46+08:00

While cannabis plants are best known for the psychotropic effects of THC, Cannabis sativa contains a wealth of secondary metabolites. Many of these compounds, known under the umbrella term “cannabinoids”, have potential applications as therapeutics.

Combining synthetic, computational, and structural biology improves key enzyme in cannabinoid biosynthesis2022-05-18T12:58:46+08:00
Go to Top